EFMH
UTHR icon

E Fund Management (HK)’s United Therapeutics UTHR Stock Holding History

E Fund Management (HK)’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$24.9K Buy
46
+16
+53% +$9.01K 0.01% 269
2026
Q1 		$17.8K Buy
+30
New +$14.9K 0.01% 217

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

E Fund Management (HK)'s UTHR Position: Q2 2026 in Review

E Fund Management (HK) increased its United Therapeutics (UTHR) stake by 53% in Q2 2026, buying an estimated $9.01K and bringing the position to 46 shares worth $24.9K. The position accounts for 0.01% of the portfolio, ranked #269.

E Fund Management (HK) first reported a position in UTHR in Q1 2026 and has held it in 2 quarters since. 882 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • E Fund Management (HK) held 46 shares of United Therapeutics worth $24.9K as of Q2 2026.
  • E Fund Management (HK) bought 16 United Therapeutics shares in Q2 2026, an estimated $9.01K.
  • United Therapeutics made up 0.01% of E Fund Management (HK)'s portfolio in Q2 2026, its #269 holding.
  • E Fund Management (HK) first reported a position in United Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • 882 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on E Fund Management (HK)'s 13F filing for Q2 2026, filed 22 Jul 2026.